Extended Data Fig. 3: Previously reported synthetic routes to advanced drug intermediates.

In past protocols, extensive functional group interconversions, redox manipulations and protecting group strategies were necessary to access medicinally relevant building blocks 79 and 2. Ms, mesyl.